Dulcolax
(Bisacodyl)Phase 3Small molecule
Boehringer IngelheimBisacodyl is used to treat constipation by stimulating bowel movements and helping you have a bowel movement. It's also used to prepare the bowel before medical procedures like colonoscopies.[1] Dulcolax is currently being investigated across 4 indications[3], with its most advanced program in Phase 3.[1]
Dulcolax is one of 90 small molecule programs targeting Constipation Disorder. It is currently in Phase 3.
4
Indications
32
Total Trials
4
Active Trials
89
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
56 competitors in Autism Spectrum Disorder
#DrugCompanyPhaseTrials
1Buspar
Bristol-Myers SquibbApproved
Namenda
AbbVieApproved
Lioresal
NovartisApproved
Epidiolex
Jazz PharmaceuticalsApproved
Aricept
EisaiApproved
Marinol
Jazz PharmaceuticalsApproved
Neurontin
VViatris Specialty LLC
Approved
Abilify
OtsukaApproved
Strattera
MMap77
Approved
Bendopa
MMerz North America, Inc.
Approved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Constipation5 trials
Show 2 more trials
Lubiprostone for Functional Constipation in the Under 18 Years Patients
Completed·—·Phase 3·NCT05144295·274 enrolled
Bowel Preparation4 trials
Colonoscopy4 trials
Bowel Preparation for Colonoscopy2 trials
Function2 trials
Bisacodyl Oral for Lowering Dysfunction (of Tenckhoff Catheter)
Not yet recruiting·—·Phase 4·NCT07351357·398 enrolled
14 more indications
Colorectal1 trial
Colorectal Surgery1 trial
Female1 trial
Paralysis1 trial
Autism Spectrum Disorder1 trial
Hospitalized Patients1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Bisacodyl. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 3[1]
- Company